2025. [Complementary Strategy of RSVpreF Vaccination/Nirsevimab versus Nirsevimab Alone for the Prevention of RSV Infection in Infants in Italy: A Cost-Minimization Analysis]. Farmeconomia. Health Economics and Therapeutic Pathways. 26, 1 (Jul. 2025). DOI:https://doi.org/10.7175/fe.v26i1.1583.